182 related articles for article (PubMed ID: 15589853)
1. Exogenous luteinizing hormone in controlled ovarian hyperstimulation for assisted reproduction techniques.
Ferraretti AP; Gianaroli L; Magli MC; D'angelo A; Farfalli V; Montanaro N
Fertil Steril; 2004 Dec; 82(6):1521-6. PubMed ID: 15589853
[TBL] [Abstract][Full Text] [Related]
2. Clinical effects of ovulation induction with recombinant follicle-stimulating hormone supplemented with recombinant luteinizing hormone or low-dose recombinant human chorionic gonadotropin in the midfollicular phase in microdose cycles in poor responders.
Berkkanoglu M; Isikoglu M; Aydin D; Ozgur K
Fertil Steril; 2007 Sep; 88(3):665-9. PubMed ID: 17292895
[TBL] [Abstract][Full Text] [Related]
3. Ovarian response and pregnancy outcome in poor-responder women: a randomized controlled trial on the effect of luteinizing hormone supplementation on in vitro fertilization cycles.
Barrenetxea G; Agirregoikoa JA; Jiménez MR; de Larruzea AL; Ganzabal T; Carbonero K
Fertil Steril; 2008 Mar; 89(3):546-53. PubMed ID: 17531989
[TBL] [Abstract][Full Text] [Related]
4. A randomized controlled trial of increasing recombinant follicle-stimulating hormone after initiating a gonadotropin-releasing hormone antagonist for in vitro fertilization-embryo transfer.
Propst AM; Bates GW; Robinson RD; Arthur NJ; Martin JE; Neal GS
Fertil Steril; 2006 Jul; 86(1):58-63. PubMed ID: 16753156
[TBL] [Abstract][Full Text] [Related]
5. Effects of recombinant human luteinizing hormone supplementation on ovarian stimulation and the implantation rate in down-regulated women of advanced reproductive age.
Fábregues F; Creus M; Peñarrubia J; Manau D; Vanrell JA; Balasch J
Fertil Steril; 2006 Apr; 85(4):925-31. PubMed ID: 16580376
[TBL] [Abstract][Full Text] [Related]
6. Lower apoptosis rate in human cumulus cells after administration of recombinant luteinizing hormone to women undergoing ovarian stimulation for in vitro fertilization procedures.
Ruvolo G; Bosco L; Pane A; Morici G; Cittadini E; Roccheri MC
Fertil Steril; 2007 Mar; 87(3):542-6. PubMed ID: 17126339
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of recombinant human follicle-stimulating hormone in improving oocyte quality in assisted reproductive techniques.
Cheon KW; Byun HK; Yang KM; Song IO; Choi KH; Yoo KJ
J Reprod Med; 2004 Sep; 49(9):733-8. PubMed ID: 15493565
[TBL] [Abstract][Full Text] [Related]
8. The serum follicle-stimulating hormone-to-luteinizing hormone ratio at the start of stimulation with gonadotropins after pituitary down-regulation is inversely correlated with a mature oocyte yield and can predict "low responders".
Ho JY; Guu HF; Yi YC; Chen MJ; Ho ES
Fertil Steril; 2005 Apr; 83(4):883-8. PubMed ID: 15820795
[TBL] [Abstract][Full Text] [Related]
9. Follicular phase serum levels of luteinizing hormone do not influence delivery rates in in vitro fertilization cycles down-regulated with a gonadotropin-releasing hormone agonist and stimulated with recombinant follicle-stimulating hormone.
Cabrera RA; Stadtmauer L; Mayer JF; Gibbons WE; Oehninger S
Fertil Steril; 2005 Jan; 83(1):42-8. PubMed ID: 15652885
[TBL] [Abstract][Full Text] [Related]
10. The evaluation of recombinant LH supplementation in patients with suboptimal response to recombinant FSH undergoing IVF treatment with GnRH agonist down-regulation.
Yazıcı Yılmaz F; Görkemli H; Çolakoğlu MC; Aktan M; Gezginç K
Gynecol Endocrinol; 2015 Feb; 31(2):141-4. PubMed ID: 25237892
[TBL] [Abstract][Full Text] [Related]
11. Small doses of LH activity are needed early in ovarian stimulation for better quality oocytes in IVF-ET.
Drakakis P; Loutradis D; Kallianidis K; Liapi A; Milingos S; Makrigiannakis A; Dionyssiou-Asteriou A; Michalas S
Eur J Obstet Gynecol Reprod Biol; 2005 Jul; 121(1):77-80. PubMed ID: 15989987
[TBL] [Abstract][Full Text] [Related]
12. The use of recombinant luteinizing hormone in patients undergoing assisted reproductive techniques with advanced reproductive age: a systematic review and meta-analysis.
Hill MJ; Levens ED; Levy G; Ryan ME; Csokmay JM; DeCherney AH; Whitcomb BW
Fertil Steril; 2012 May; 97(5):1108-14.e1. PubMed ID: 22365075
[TBL] [Abstract][Full Text] [Related]
13. A comparison of 3-day and daily follicle-stimulating hormone injections on stimulation days 1-6 in women undergoing controlled ovarian hyperstimulation.
Scholtes MC; Schnittert B; van Hoogstraten D; Verhoeven HC; Zrener A; Warne DW
Fertil Steril; 2004 Apr; 81(4):996-1001. PubMed ID: 15066454
[TBL] [Abstract][Full Text] [Related]
14. Can pregnancy rate be improved in gonadotropin-releasing hormone (GnRH) antagonist cycles by administering GnRH agonist before oocyte retrieval? A prospective, randomized study.
Schachter M; Friedler S; Ron-El R; Zimmerman AL; Strassburger D; Bern O; Raziel A
Fertil Steril; 2008 Oct; 90(4):1087-93. PubMed ID: 18023439
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of highly purified human menopausal gonadotropin vs. recombinant follicle-stimulating hormone in first-cycle in vitro fertilization-intracytoplasmic sperm injection patients.
Hompes PG; Broekmans FJ; Hoozemans DA; Schats R;
Fertil Steril; 2008 Jun; 89(6):1685-93. PubMed ID: 17681325
[TBL] [Abstract][Full Text] [Related]
16. Outcome of intracytoplasmic sperm injection in patients with polycystic ovary syndrome or isolated polycystic ovaries.
Esinler I; Bayar U; Bozdag G; Yarali H
Fertil Steril; 2005 Oct; 84(4):932-7. PubMed ID: 16213846
[TBL] [Abstract][Full Text] [Related]
17. Impact of luteal phase support on pregnancy rates in intrauterine insemination cycles: a prospective randomized study.
Erdem A; Erdem M; Atmaca S; Guler I
Fertil Steril; 2009 Jun; 91(6):2508-13. PubMed ID: 18692788
[TBL] [Abstract][Full Text] [Related]
18. Clinical efficacy of highly purified urinary FSH versus recombinant FSH in volunteers undergoing controlled ovarian stimulation for in vitro fertilization: a randomized, multicenter, investigator-blind trial.
Baker VL; Fujimoto VY; Kettel LM; Adamson GD; Hoehler F; Jones CE; Soules MR
Fertil Steril; 2009 Apr; 91(4):1005-11. PubMed ID: 18367182
[TBL] [Abstract][Full Text] [Related]
19. Management of poor responders: can outcomes be improved with a novel gonadotropin-releasing hormone antagonist/letrozole protocol?
Schoolcraft WB; Surrey ES; Minjarez DA; Stevens JM; Gardner DK
Fertil Steril; 2008 Jan; 89(1):151-6. PubMed ID: 17482177
[TBL] [Abstract][Full Text] [Related]
20. Cryopreserved-thawed embryo transfer in natural or down-regulated hormonally controlled cycles: a retrospective study.
Gelbaya TA; Nardo LG; Hunter HR; Fitzgerald CT; Horne G; Pease EE; Brison DR; Lieberman BA
Fertil Steril; 2006 Mar; 85(3):603-9. PubMed ID: 16500326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
